5 powerful seeds that help lower bad cholesterol naturally and the right way to consume them ...

An analysis of 2019 insurance claim data and national survey results shows that the prevalence of digestive diseases in the ...

Colorectal cancer (CRC) remains one of the most prevalent malignancies and a leading cause of cancer-related mortality worldwide. Beyond tumor-intrinsic ...

LOQTORZI® net revenue more than doubled to $40.8 million in 2025 from $19.1 million in 2024 –– Reduced secured and convertible debt by 90% from ...

The global MedTech market is projected to grow at a compound annual growth rate (CAGR) of approximately 7% over the next five years. This expansion is driven by rising volumes of surgical and ...

Phase 1 dose-escalation advancing as planned, targeting SMARCA4 (BRG1)-mutant cancers with a focus on non-small cell lung ...

BioNTech on track for a catalyst-rich year with six late-stage data readouts expected across immunomodulators, antibody-drug conjugates and mRNA cancer immunotherapies Increased focus on PD-L11/VEGF-A ...

Therapeutic developers are increasingly rebuilding their workflows around AI to bring drugs to patients faster.

Barclays 28th Annual Global Healthcare Conference March 10, 2026 8:30 AM EDTCompany ParticipantsDaniel Faga - President, CEO ...

Barclays 28th Annual Global Healthcare Conference March 10, 2026 11:30 AM EDTCompany ParticipantsRyan Cohlhepp - ...

LOQTORZI net revenue more than doubled to $40.8 million in 2025 from $19.1 million in 2024 - - Reduced secured and convertible debt by 90% from $480 million to $38.8 million over 2024-2025 - - $172.1 ...

Reviewing the role, regulatory mechanisms and therapeutic potential of METTL16 in cancer Cancer remains a leading cause of mortality, with its onset ...